SIGNIFICANT ITEMS (SIs) FY 2013 Senate Appropriations Committee Report and FY 2013 House Appropriations Committee Report Table of Contents National Cancer Institute (NCI) 1 National Heart, Lung, and Blood Institute (NHLBI) 19 National Institute of Dental and Craniofacial Research (NIDCR) 33 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 35 National Institute of Neurological Disorders and Stroke (NINDS) 43 National Institute of Allergy and Infectious Diseases (NIAID) 51 National Institute of General Medical Sciences (NIGMS) 63 National Institute of Child Health and Human Development (NICHD) 65 National Eye Institute (NEI) 79 National Institute of Environmental Health Sciences (NIEHS) 83 National Institute of Environmental Health Sciences (NIEHS) Superfund 87 National Institute on Aging (NIA) 89 National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 97 National Institute on Deafness and Other Communication Disorders (NIDCD) 103 National Institute of Mental Health (NIMH) 117 National Institute on Drug Abuse (NIDA) 125 National Institute on Alcohol Abuse and Alcoholism (NIAAA) 133 National Institute on Minority Health and Health Disparities (NIMHD) 135 National Center for Complementary and Alternative Medicine (NCCAM) 139 National Center for Advancing Translational Sciences (NCATS) 141 National Library of Medicine (NLM) 147 Office of the Director (OD) 149 A Access to Natural Product Collections ....................................................................................... 139 Alzheimer’s Disease ............................................................................................................. 89, 149 Amyotrophic Lateral Sclerosis [ALS] .......................................................................................... 43 Angiogenesis ................................................................................................................................... 1 Antibacterial Resistance................................................................................................................ 51 Anti-Malarial Medications ............................................................................................................ 52 Asthma .......................................................................................................................................... 19 Autism ......................................................................................................................................... 117 B Basic Behavioral Research Translation ........................................................................................ 20 Biology of Aging .......................................................................................................................... 90 Breast Cancer .................................................................................................................................. 2 Burden of Digestive Diseases ....................................................................................................... 35 C Cancer Disparities ........................................................................................................................... 3 Cardiovascular Disease ................................................................................................................. 21 Career Development Awards for Clinical Researchers .............................................................. 150 Cerebral Palsy ............................................................................................................................. 151 Children in Military Families........................................................................................................ 65 Chimpanzees ............................................................................................................................... 152 Chromosome Abnormalities ......................................................................................................... 66 Chronic Obstructive Pulmonary Disease [COPD] ........................................................................ 23 Chronic Pelvic Pain....................................................................................................................... 35 Class B Animal Dealers .............................................................................................................. 153 Clinical and Translational Science Awards [CTSAs] ................................................................. 141 Clinical Trials for Human Communication Disorders ................................................................ 103 Cognitive Interventions ................................................................................................................. 91 Collaboration With DOE ............................................................................................................ 154 Collaboration With the FDA ............................................................................................... 125, 155 Combination HIV Prevention ..................................................................................................... 118 Congenital Diaphragmatic Hernia [CDH] .................................................................................. 141 Congenital Muscular Dystrophy ................................................................................................. 156 Cystic Fibrosis [CF] .................................................................................................................... 157 D Dementia and Hearing Loss ........................................................................................................ 104 Demographic Research ........................................................................................................... 67, 92 Diabetes....................................................................................................................................... 135 Diabetes Prevention ...................................................................................................................... 36 Diabetic Eye Disease .................................................................................................................... 79 i Disaster Information Management ............................................................................................. 147 Doctors of Veterinary Medicine [DVMs] and Loan Repayment Programs ............................... 158 Down Syndrome ......................................................................................................................... 159 Drug Allergy ............................................................................................................................... 160 Duchenne Muscular Dystrophy .................................................................................................. 161 Dystonia ................................................................................................................................ 44, 142 E Early Detection, Diagnosis, and Intervention ............................................................................. 105 Eating Disorders.......................................................................................................................... 163 Education .................................................................................................................................... 126 Endocrine Disruption and Women’s Health ................................................................................. 83 Eosinophil-Associated Disorders ................................................................................................ 164 Epilepsy......................................................................................................................................... 45 F False Positives and Replications ................................................................................................. 165 Fecal Incontinence ........................................................................................................................ 37 Food Allergies ............................................................................................................................... 53 Fragile X-Associated Disorders .................................................................................................. 166 Functional Gastrointestinal Disorders [FGIDs] ............................................................................ 38 G Genetic Basis of Eye Disease ....................................................................................................... 79 Glomerular Disease ..................................................................................................................... 168 Gulf Oil Spill................................................................................................................................. 84 H Hair Cell Regeneration and Replacement ................................................................................... 106 Headache Disorders ...................................................................................................................... 46 Hearing Aids and Cochlear Implants .......................................................................................... 107 Hearing Impairment Among Children and Young Adults .......................................................... 108